ISSN: 2376-127X

Journal of Pregnancy and Child Health
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Research Article   
  • JPCH, Vol 10(4)
  • DOI: 10.4172/2376-127X.1000595

The Effect of a Novel Multi-Ingredient Supplement in Pregnant Women

Marco Rigatti1, Agostino Menditto2, Renato De Stefano2*, Civetta Antonio3, Umberto Landri4, Roberto Passaro4, Mario Passaro4, Fabrizio Paolillo Diodati4, Alessandro Nicotra4, Emio Cafarelli4, Ermanno Barletta4, Antonio Esposito4 and Pierluigi Pozzuoli4
1Clinica Sanatrix, Naples, Italy
2Clinica Mediterranea, Naples, Italy
3Andrea Grimaldi Medical Care, Naples, Italy
4Naples, Italy
*Corresponding Author: Renato De Stefano, Grimaldi Clinic, Naples, Italy, Email: destefanorenato29@gmail.com

Received: 01-Jun-2023 / Manuscript No. jpch-23-102372 / Editor assigned: 05-Jun-2023 / PreQC No. jpch-23-102372 (PQ) / Reviewed: 14-Jun-2023 / QC No. jpch-23-102372 / Revised: 21-Jun-2023 / Manuscript No. Jpch-23-102372(R) / Accepted Date: 30-Jun-2023 / Published Date: 30-Jun-2023 DOI: 10.4172/2376-127X.1000595

Abstract

Objective: to investigate the effects of a novel multi-ingredient supplement comprised of high dose whey protein, to improve maternal and perinatal outcomes in pregnant women

Methods: This was an observational retrospective study. Women who received oral supplementation with a novel multi-ingredient supplement (PSIPROTO ®), comprised of high dose whey protein, were compared with women who did not. Inclusion criteria were singleton pregnancy with body mass index (BMI) higher than 25. The primary outcome of the study was the incidence of adverse pregnancy outcome

Results: 400 women, 200 for each group, were included in the study. The two groups were similar in terms of maternal demographics, and both of them had similar BMI. Maternal age and smoking rate were also similar. Women who received the intervention had a significantly lower maternal weight gain, and lower risk of low birth weight. Notably, 4 women in the intervention group reported intrauterine growth restriction before the intervention, and solved after 2 months of supplementation.

Conclusion: Our retrospective cohort of singleton gestations with BMI >25 showed that PSIPROTO is a safe and efficacy supplement in pregnancy.

Keywords

Supplementation; Iron; Anemia; Pregnancy; Diet; Protein

Introduction

In pregnant women, a healthy lifestyle includes appropriate weight gain, a balanced diet, regular aerobix exercise, and appropriate vitamin and mineral supplementation [1-3]. Every day approximately 300 extra calories are needed, with a balanced diet of protein, fruits, vegetalbes and whole grains [4]. Animal-based foods (meat, poultry, fish, eggs, and dairy foods) tend to be good sources of complete protein, while plantbased foods (fruits, vegetables, grains, nuts, and seeds) often lack one or more essential amino acid [5]. Proteins are of paramount importance during pregnancy. A pregnant patient should get a minimum of 60 grams of protein a day, which account for approximately 20-25% of the total calorie intake [6]. Whey protein comprises soluble whey proteins and its benefits are well described in the literature [7]. During pregnancy, whey protein intake and high protein supplementation are associated with reduced risk of excessive maternal weight gain [8].

Materials and Methods

This was an observational retrospective study. Data were collected in a dedicated encrypted database and anonymized. Women who received oral supplementation with a novel multi-ingredient supplement (PSIPROTO ®), comprised of high dose whey protein, were compared with women who did not. PSIPROTO ® contains a blend called PSINOTRIP ®, and Volactive ® as source of UltraWhey high-performance proteins (7.6 grams for 10 gr of PSIPROTO). PSINOTRIP included for 10 gr of PSIPROTO the following: psyllium fiber (0.5 g); myoinositol (0.5 g); L-Tryptophan (0.15 g); Magnesium bisglycinate (0.1 g); and vitamin D (1.000 UI). The intervention was taken at the dose of 20 gr per day starting from 14 weeks for 3 months (until 26 weeks). Inclusion criteria were singleton pregnancy with body mass index (BMI) higher than 25. Exclusion criteria were twin pregnancies and multiple gestations. The primary outcome of the study was the incidence of adverse pregnancy outcome, including maternal and perinatal outcomes. The secondary outcomes were maternal weight gain, and birth weight. Statistical analysis was performed using Statistical Package for Social Sciences (SPSS) v. 19.0 (IBM Inc., Armonk, NY, USA). Data were shown as means± standard deviation or as number (percentage). Dichotomous data were compared using the chi-square. Comparisons between groups were performed with the use of the T-test to test group means by assuming equal within-group variances. A sample size of 200 women for each group was planned.

Results

400 women, 200 for each group were included in the study. Therefore, 388 participants were available for the final analysis. The two groups were similar in terms of maternal demographics, and both of them had similar BMI. Maternal age and smoking rate were also similar. Women who received the intervention had a significantly lower maternal weight gain, with a mean difference of -5.50 kg, and lower risk of low birth weight. Notably, 4 women in the intervention group reported intrauterine growth restriction before the intervention, and solved after 2 months of supplementation. However, the sample size was too sample to run statistics [Table 1]

  Intervention group Control group P-value
N = 190 N = 198
Maternal weight gain (kg) 8.3±3.5 13.8±7.4 <0.01
>15kg during pregnancy 20 (10.5%) 37 (18.7%) 0.03
Intrauterine growth restriction 13 (6.8%) 18 (9.1%) NS
Miscarriage 7 (3.7%) 5 (2.5%) NS
Cesarean delivery 51 (26.8%) 63 (31.8%) NS
Low birth weight 18 (9.5%) 35 (17.7%) 0.02
Fetal macrosomia 12 16 NS
Boldaface data, statistically significant

Table 1: Primary and secondary outcomes.

Conclusion

Our retrospective cohort of singleton gestations showed that that PSIPROTO ® is a safe and efficacy supplement in pregnancy that improves maternal and perinatal outcome. Future, large well-designed placebo-controlled randomized trials are needed to confirm our findings.

References

  1. Berghella V, Saccone G (2017) Exercise in pregnancy! Am J Obstet Gynecol 216: 335-337.
  2. Indexed at, Crossref, Google Scholar

  3. Saccone G, Saccone I, Berghella V(2016) Omega-3 long-chain polyunsaturated fatty acids and fish oil supplementation during pregnancy: which evidence? J Matern Fetal Neonatal Med 29: 2389-97.
  4. Indexed at, Crossref, Google Scholar

  5. Menezes R, Lelijveld N, Wrottesley SV, Brennan E, Mates E, et al. (2022) Integrating Women and Girls' Nutrition Services into Health Systems in Low- and Middle-Income Countries: A Systematic Review. Nutrients 14: 4488.
  6. Indexed at, Crossref, Google Scholar

  7. Elliott Sale KJ, Graham A, Hanley SJ, Blumenthal S, Sale C, et al. (2019) Modern dietary guidelines for healthy pregnancy; maximising maternal and foetal outcomes and limiting excessive gestational weight gain. Eur J Sport Sci 19: 62-70.
  8. Indexed at, Crossref, Google Scholar

  9. Koletzko B, Cremer M, Flothkötter M, Graf C, Hauner H, et al. (2018). Diet and Lifestyle Before and During Pregnancy - Practical Recommendations of the Germany-wide Healthy Start - Young Family Network. Geburtshilfe Frauenheilkd 78: 1262-1282.
  10. Indexed at, Crossref, Google Scholar

  11. Koletzko B, Bauer CP, Bung P, Cremer M, Flothkötter M, et al. (2013) German national consensus recommendations on nutrition and lifestyle in pregnancy by the 'Healthy Start - Young Family Network'. Ann Nutr Metab 63: 311-22.
  12. Indexed at, Crossref, Google Scholar

  13. Vasconcelos QDJS, Bachur TPR, Aragão GF (2021) Whey protein supplementation and its potentially adverse effects on health: a systematic review. Appl Physiol Nutr Metab 46: 27-33.
  14. Indexed at, Crossref, Google Scholar

  15. Clark DC (2018) Association of Dairy Protein Intake During Pregnancy with Birth Weight. Food Nutr Bull 39: S54-S59.
  16. Indexed at, Crossref, Google Scholar

Citation: Rigatti M, Menditto A, Stefano RD, Antonio C, Landri U, et al. (2023) The Effect of a Novel Multi-Ingredient Supplement in Pregnant Women. J Preg Child Health 10: 595. DOI: 10.4172/2376-127X.1000595

Copyright: © 2023 Rigatti M, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top